FSTL3 promotes tumor immune evasion and attenuates response to anti-PD1 therapy by stabilizing c-Myc in colorectal cancer
Article in Cell Death & Disease (February 2024)
The most recent citing publications are shown below. View all 31 publications that cite this research output on Dimensions.
Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapy
Article in Journal for ImmunoTherapy of Cancer (November 2023)
Deciphering the complexities of cancer cell immune evasion: Mechanisms and therapeutic implications
Article in Advances in Cancer Biology - Metastasis (October 2023)